Wird geladen...
Immunogenicity assay of the Leishmune(®) vaccine against canine visceral leishmaniasis in Brazil
Leishmune(®) is the industrialized version of the FML-saponin vaccine which has been shown to develop 92–95% protection in vaccinated dogs and 76–80% vaccine efficacy against field canine visceral leishmaniasis (CVL) in Brazil. Leishmune(®) has been proven to be safe and tolerable and a transmission...
Gespeichert in:
| Veröffentlicht in: | Vaccine |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier Ltd.
2008
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7173152/ https://ncbi.nlm.nih.gov/pubmed/18675868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.07.029 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|